Strategic partnership: Press Ganey acquiring Forsta

Press Ganey, a healthcare-focused patient experience company announced its intention to acquire human experience and research technology platform Forsta, the pair said Feb. 7.

The deal is expected to close in the first or second quarter of 2022 and will help Press Ganey grow its technology offerings and expand them globally. Financial terms of the acquisition were not disclosed.

“This alliance propels Press Ganey into a new future. Our unparalleled excellence in healthcare consulting, and proprietary data and analytics, will soon be infused with even more innovation and speed by Forsta’s world-class experience and research technology platform,” said Patrick T. Ryan, chairman and CEO, Press Ganey, in a prepared statement. “I’m beyond thrilled to welcome Forsta to the Press Ganey family. This is a huge leap forward in helping our customers to do their jobs better every day.”

The marriage of the two companies will provide Press Ganey’s clients access to a suite of customer and employee experience and market research technology. For its part, Forsta will gain access to new investment and growth opportunities along with enhanced consulting and change management experience.

Press Ganey manages almost 476 million patient engagements annually while Forsta’s Human Experience platform serves more than 5,000 customers worldwide, according to the statement.

“Press Ganey was the first company to truly recognize and respond to the importance of patient experience, and the company continues to lead innovation in the field. I’m excited to join forces with such a forward-thinking, highly respected company, and eager for the benefits this investment will bring to our customers,” Kyle Ferguson, CEO of Forsta, said in the same statement.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.